Peterson Caryn — SEC insider filings

SEC reporting owner CIK 1857256. 18 insider filings on record with FilingPulse; latest filed 2026-10-29.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2021-04-20 to 2026-10-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Gossamer Bio, Inc. (GOSS)Chief Development Officer17—5 legs · 24,995 sh · $152,17548
Aspen Neuroscience, Inc. (ASPE)Director1———

Insider filings — Peterson Caryn

FiledFormIssuerReported transactionsSource
2026-10-293Aspen Neuroscience, Inc. (ASPE)Holdings only — no transactions reportedEDGAR
2026-08-264Gossamer Bio, Inc. (GOSS)Grant/award (A): 5,800,051 (derivative) @ $0EDGAR
2026-03-204Gossamer Bio, Inc. (GOSS)Disposition to issuer (D): 506,250 (derivative) · Disposition to issuer (D): 440,000 (derivative) · Disposition to issuer (D): 375,000 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Disposition to issuer (D): 157,500 (derivative) · Disposition to issuer (D): 157,500 (derivative) · +18 moreEDGAR
2026-01-054Gossamer Bio, Inc. (GOSS)Grant/award (A): 84,500 @ $0 · Grant/award (A): 506,250 (derivative) @ $0EDGAR
2025-10-024Gossamer Bio, Inc. (GOSS)Grant/award (A): 125,000 @ $0EDGAR
2025-03-064Gossamer Bio, Inc. (GOSS)Grant/award (A): 440,000 (derivative) @ $0EDGAR
2024-03-194Gossamer Bio, Inc. (GOSS)Sale (S): 4,018 @ $1.33EDGAR
2024-01-044Gossamer Bio, Inc. (GOSS)Grant/award (A): 375,000 (derivative) @ $0EDGAR
2023-11-224Gossamer Bio, Inc. (GOSS)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2023-05-094Gossamer Bio, Inc. (GOSS)Disposition to issuer (D): 48,500 (derivative) · Disposition to issuer (D): 13,750 (derivative) · Disposition to issuer (D): 34,175 (derivative) · Disposition to issuer (D): 28,250 (derivative) · Disposition to issuer (D): 31,750 (derivative) · Disposition to issuer (D): 190,000 (derivative) · +6 moreEDGAR
2023-03-224Gossamer Bio, Inc. (GOSS)Grant/award (A): 157,500 (derivative) @ $0EDGAR
2023-03-204Gossamer Bio, Inc. (GOSS)Sale (S): 7,564 @ $1.10EDGAR
2022-12-094Gossamer Bio, Inc. (GOSS)Grant/award (A): 157,500 (derivative) @ $0EDGAR
2022-10-254Gossamer Bio, Inc. (GOSS)Sale (S): 4,757 @ $12.07EDGAR
2022-03-174Gossamer Bio, Inc. (GOSS)Sale (S): 6,279 @ $8.28EDGAR
2022-01-104Gossamer Bio, Inc. (GOSS)Grant/award (A): 190,000 (derivative) @ $0EDGAR
2021-10-264Gossamer Bio, Inc. (GOSS)Sale (S): 2,377 @ $12.25EDGAR
2021-04-204Gossamer Bio, Inc. (GOSS)Grant/award (A): 10,820 @ $0 · Grant/award (A): 31,750 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1857256 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs